Ani Pharms patent expiration
1. Atacand patent expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US5196444 (Pediatric) | ANI PHARMS | 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof |
Dec, 2012
(11 years ago) | |
| US5534534 | ANI PHARMS | Pharmaceutical compositions for oral use and method of preparing them |
Jul, 2013
(11 years ago) | |
|
US5534534 (Pediatric) | ANI PHARMS | Pharmaceutical compositions for oral use and method of preparing them |
Jan, 2014
(10 years ago) | |
Drugs and Companies using CANDESARTAN CILEXETIL ingredient
Market Authorisation Date: 04 June, 1998
Treatment: NA
Dosage: TABLET
How can I launch a generic of ATACAND before it's drug patent expiration?
More Information on Dosage
ATACAND family patents
2. Atacand Hct patent expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US5196444 (Pediatric) | ANI PHARMS | 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof |
Dec, 2012
(11 years ago) | |
| US5534534 | ANI PHARMS | Pharmaceutical compositions for oral use and method of preparing them |
Jul, 2013
(11 years ago) | |
|
US5534534 (Pediatric) | ANI PHARMS | Pharmaceutical compositions for oral use and method of preparing them |
Jan, 2014
(10 years ago) | |
| US5958961 | ANI PHARMS | Pharmaceutical composition for angiotensin II-mediated diseases |
Jun, 2014
(10 years ago) | |
| US5721263 | ANI PHARMS | Pharmaceutical composition for angiotensin II-mediated diseases |
Feb, 2015
(9 years ago) | |
Drugs and Companies using CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE ingredient
Market Authorisation Date: 05 September, 2000
Treatment: Treatment of hypertension
Dosage: TABLET
How can I launch a generic of ATACAND HCT before it's drug patent expiration?
More Information on Dosage
ATACAND HCT family patents
3. Innopran Xl patent
expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6500454 | ANI PHARMS | Timed, sustained release systems for propranolol |
Oct, 2021
(2 years ago) | |
Drugs and Companies using PROPRANOLOL HYDROCHLORIDE ingredient
Market Authorisation Date: 12 March, 2003
Treatment: NA
Dosage: CAPSULE, EXTENDED RELEASE
More Information on Dosage
INNOPRAN XL family patents
4. Purified Cortrophin Gel patent expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11975047 | ANI PHARMS | Methods for storing and warming purified corticotropin compositions |
Oct, 2043
(19 years from now) | |
Drugs and Companies using CORTICOTROPIN ingredient
Market Authorisation Date: 01 January, 1982
Treatment: To induce a diuresis or a remission of proteinuria in the nephrotic syndrome without uremia of the idiopathic type or that due to lupus erythematosus
Dosage: INJECTABLE
More Information on Dosage
PURIFIED CORTROPHIN GEL family patents
5. Veregen patent expiration
VEREGEN IPR and PTAB Proceedings
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5968973 | ANI PHARMS | Method for treating hyperplasia |
Apr, 2017
(7 years ago) | |
| US5795911 | ANI PHARMS | Composition for treating Condyloma acuminata |
Oct, 2020
(3 years ago) | |
| US10434059 | ANI PHARMS | Medicament for the treatment of viral skin and tumour diseases |
Nov, 2022
(1 year, 8 months ago) | |
| US9770406 | ANI PHARMS | Medicament for the treatment of viral skin and tumour diseases |
Jul, 2025
(11 months from now) | |
| US7858662 | ANI PHARMS | Medicament for the treatment of viral skin and tumour diseases |
Oct, 2026
(2 years from now) | |
Drugs and Companies using SINECATECHINS ingredient
Market Authorisation Date: 31 October, 2006
Treatment: Treatment of genital warts
Dosage: OINTMENT
More Information on Dosage
VEREGEN family patents